- Report
- July 2024
- 185 Pages
Global
From €3688EUR$4,000USD£3,079GBP
- Report
- May 2024
- 128 Pages
Global
From €3688EUR$4,000USD£3,079GBP
- Report
- September 2024
- 173 Pages
Global
From €3688EUR$4,000USD£3,079GBP
- Report
- July 2024
- 70 Pages
Global
From €3688EUR$4,000USD£3,079GBP
- Report
- July 2024
- 68 Pages
Global
From €2305EUR$2,500USD£1,924GBP
- Report
- September 2023
- 179 Pages
Global
From €3688EUR$4,000USD£3,079GBP
- Report
- June 2025
- 147 Pages
Global
From €3642EUR$3,950USD£3,040GBP
- Report
- May 2026
- 150 Pages
India
From €4471EUR$4,850USD£3,733GBP
- Report
- May 2026
- 150 Pages
Indonesia
From €4471EUR$4,850USD£3,733GBP
- Report
- May 2026
- 150 Pages
Italy
From €4471EUR$4,850USD£3,733GBP
- Report
- May 2026
- 150 Pages
Japan
From €4471EUR$4,850USD£3,733GBP
- Report
- May 2026
- 150 Pages
Malaysia
From €4471EUR$4,850USD£3,733GBP
- Report
- May 2026
- 150 Pages
Mexico
From €4471EUR$4,850USD£3,733GBP
- Report
- May 2026
- 150 Pages
Netherlands
From €4471EUR$4,850USD£3,733GBP
- Report
- May 2026
- 150 Pages
China
From €4471EUR$4,850USD£3,733GBP
- Report
- May 2026
- 150 Pages
Saudi Arabia
From €4471EUR$4,850USD£3,733GBP
- Report
- May 2026
- 150 Pages
South Africa
From €4471EUR$4,850USD£3,733GBP
- Report
- May 2026
- 150 Pages
South Korea
From €4471EUR$4,850USD£3,733GBP
- Report
- May 2026
- 150 Pages
Spain
From €4471EUR$4,850USD£3,733GBP
- Report
- May 2026
- 150 Pages
Thailand
From €4471EUR$4,850USD£3,733GBP

The Inhalers and Nebulisers market is a segment of the medical device industry that focuses on the development and production of devices used to deliver medication to the lungs. Inhalers and nebulisers are used to treat a variety of respiratory conditions, including asthma, COPD, and cystic fibrosis. Inhalers are handheld devices that deliver medication directly to the lungs in the form of a mist or aerosol. Nebulisers are larger devices that use a compressor to convert liquid medication into a mist that can be inhaled.
Inhalers and nebulisers are used by millions of people around the world, and the market is expected to grow in the coming years. Companies in the market include GlaxoSmithKline, Boehringer Ingelheim, AstraZeneca, Novartis, and Teva Pharmaceuticals. These companies are involved in the development and production of inhalers and nebulisers, as well as the research and development of new treatments for respiratory conditions. Show Less Read more